May 7, 2026 07:45AM
May 4, 2026 04:06PM
Mar 12, 2026 12:26PM
Mar 5, 2026 11:33AM
Mar 5, 2026 07:06AM
Jan 20, 2026 07:00AM
Dec 10, 2025 08:31AM Lexicon publishes preclinical data supporting LX9851 obesity treatment
Nov 10, 2025 02:33AM
Nov 6, 2025 07:59AM
Oct 14, 2025 08:01AM
Sep 22, 2025 04:00PM
Sep 11, 2025 06:50AM
Sep 9, 2025 06:50AM
Sep 8, 2025 08:31AM Lexicon submits additional data to FDA for Zynquista diabetes drug
Sep 3, 2025 06:50AM
Sep 2, 2025 08:33AM
Aug 7, 2025 08:09AM
Aug 6, 2025 12:06PM
Aug 6, 2025 07:32AM
Jun 24, 2025 06:52AM
May 13, 2025 04:01PM Lexicon Pharma (LXRX) Tops Q1 EPS by 5c
Apr 2, 2025 08:01AM
Mar 31, 2025 06:46AM
Mar 28, 2025 07:30AM
Mar 6, 2025 04:01PM
Mar 4, 2025 06:46AM
Mar 3, 2025 07:01AM
Jan 3, 2025 08:23AM Piper Sandler Explores Direct and Indirect Catalysts for Selected Biotechnology Companies
Jan 2, 2025 08:04AM
Dec 12, 2024 06:47AM
Nov 25, 2024 06:39AM
Nov 22, 2024 07:33AM
Nov 20, 2024 04:06PM
Nov 12, 2024 04:10PM
Nov 12, 2024 04:05PM Lexicon Pharma (LXRX) Misses Q3 EPS by 2c
Nov 1, 2024 07:22AM
Nov 1, 2024 06:40AM
Oct 31, 2024 07:01AM
Oct 23, 2024 09:05AM
Oct 18, 2024 05:48AM
Oct 17, 2024 07:53AM
Oct 17, 2024 06:55AM H.C. Wainwright Reiterates Buy Rating on Lexicon Pharmaceuticals (LXRX)
Oct 16, 2024 04:35PM
Oct 10, 2024 07:40AM
Oct 3, 2024 06:57AM
Sep 30, 2024 07:26AM
Sep 16, 2024 06:57AM
Sep 11, 2024 06:38AM
Sep 10, 2024 08:04AM Lexicon Pharma (LXRX): New Secondary Analysis of Phase 3 Data Demonstrates Sotagliflozin Improves TIR and Several Parameters of Glucose Control and Variability in Basal Insulin-Treated Type 2 Diabetes
Sep 7, 2024 08:00PM

409,090 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All